3-FPM (3-Fluorophenmetrazine)

represents a sophisticated fluorinated phenylmorpholine compound that has garnered significant attention in neuropharmacological research circles. As a structural analog of phenmetrazine featuring a fluorine substituent at the 3-position of the phenyl ring, 3-FPM offers unique pharmacokinetic and pharmacodynamic properties that make it invaluable for receptor binding studies, structure-activity relationship (SAR) investigations, and comparative stimulant pharmacology research. Biosynlab delivers pharmaceutical-grade 3-FPM with certified ≥99.2% purity, supporting cutting-edge scientific inquiry across USA, United Kingdom, European Union, and international research markets.

The strategic incorporation of fluorine at the meta position fundamentally alters the electronic properties of the aromatic system, influencing lipophilicity, metabolic stability, and binding affinity at monoamine transporters. This structural modification creates distinct pharmacological characteristics that differentiate 3-FPM from its parent compound and positional isomers. Researchers at institutions in London, Berlin, Amsterdam, New York, and Los Angeles utilize Biosynlab 3-FPM for investigations into dopaminergic and noradrenergic neurotransmission, contributing to the broader understanding of stimulant mechanisms and potential therapeutic applications.